Biofrontera (BFRI) Other Non-Current Liabilities (2020 - 2026)
Biofrontera (BFRI) posted quarterly Other Non-Current Liabilities of $9000.0 for Q4 2025, down 99.28% year-over-year from $1.3 million in Q4 2024, and down 25.0% quarter-over-quarter from $12000.0 in Q3 2025.
Biofrontera (BFRI) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Biofrontera's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $9000.0 for Q4 2025.
- In Q4 2025, Other Non-Current Liabilities fell 99.28% year-over-year to $9000.0; the TTM figure through Dec 2025 stood at $9000.0 (down 99.28% YoY), while the FY2025 annual figure was $9000.0, down 99.28% from the prior year.
- Other Non-Current Liabilities for Q4 2025 stood at $9000.0, down from $12000.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $12.9 million in Q4 2021, with the low at $9000.0 in Q4 2025.
- The 5-year median for Other Non-Current Liabilities is $4.9 million (2022), against an average of $5.2 million.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities sank 99.84% in 2022, then jumped 19947.62% in 2023.
- Biofrontera's Other Non-Current Liabilities stood at $12.9 million in 2021, then tumbled by 99.84% to $21000.0 in 2022, then surged by 19947.62% to $4.2 million in 2023, then tumbled by 70.31% to $1.2 million in 2024, then plunged by 99.28% to $9000.0 in 2025.
- Business Quant data shows BFRI's Other Non-Current Liabilities at $9000.0 in Q4 2025, $12000.0 in Q3 2025, and $14000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Biofrontera | 19.06 Mn | 14.35 Mn | 9.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 526,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Mar 31, 2025 | 21,000.00 |
| Dec 31, 2024 | 1.25 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | 921,000.00 |
| Mar 31, 2024 | 11.73 Mn |
| Dec 31, 2023 | 4.21 Mn |
| Sep 30, 2023 | 9.71 Mn |
| Jun 30, 2023 | 9.42 Mn |
| Mar 31, 2023 | 9.23 Mn |
| Dec 31, 2022 | 21,000.00 |
| Sep 30, 2022 | 5.65 Mn |
| Jun 30, 2022 | 8.05 Mn |
| Mar 31, 2022 | 4.14 Mn |
| Dec 31, 2021 | 12.85 Mn |
| Sep 30, 2021 | 9.30 Mn |
| Jun 30, 2021 | 8.60 Mn |